Forbion Ventures VII

Forbion / Netherlands

Read source Back to Fund Tracker

Forbion Ventures VII backs therapeutics companies from company creation and early clinical development, drawing on the manager's European life-sciences network. Its final close was reported at €890m on 15 Oct 2024. The mandate covers Europe and North America. The stated stage focus is Early Stage and Clinical Stage, with emphasis on Biotech and Health & Life Sciences.

At a glance

ManagerForbion
Close statusFinal close
Capital€890m
Reported on15 Oct 2024
Fund typeVenture
Forbion logo
Forbion Growth Opportunities IIIForbion · €1.2bn
Anterra Capital Fund IIIAnterra Capital · $100m
Vi Partners Venture FundVi Partners · CHF 150m
Ananda Core Impact Fund VAnanda Impact Ventures · €73m

Source and review

This fund record was manually reviewed on by the EverythingVC editorial team under our research methodology.

The capital figure reflects commitments reported by the cited source. It is not an estimate of remaining dry powder or current fundraising availability.